Amann VC, Dummer R
In 2016, the FDAs own internal epidemiologists urged the FDA to alert pregnant women that the data displays a potential risk of neurodevelopmental harm to the fetus
More UV intensity breaks them down faster
It is indicated for the treatment of adult patients with R/R LBCL after two or more lines of systemic therapy, including DLBCL, HGBCL, and PMBCL ( Abecma, the first anti-BCMA CAR-T product, was approved on March 26, 2021, and is indicated for treating adult patients with R/R MM after immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies targeting CD38 ( Carvykti, a bi-epitope nanobody-based anti-BCMA CAR-T product, was approved on February 28, 2022, for adults with R/R MM after four or more prior lines of therapy, including IMiDs, PIs, and an anti-CD38 monoclonal antibody ( Aucatzyla, a CD19-directed CAR-T therapy, received approval on November 8, 2024, for treating adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
Cell viability assays To evaluate cell viability, 143B and K7M2 cells were seeded in 96-well plates at a density of 5 10 3 cells per well and cultured for 24 h
